SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CROCE, Carlo Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.137
AS - Asia 10.766
EU - Europa 5.291
SA - Sud America 1.738
AF - Africa 233
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 41.189
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.757
SG - Singapore 4.039
CN - Cina 2.604
BR - Brasile 1.353
VN - Vietnam 1.196
UA - Ucraina 1.037
HK - Hong Kong 982
IT - Italia 834
DE - Germania 821
TR - Turchia 664
GB - Regno Unito 575
PL - Polonia 414
FI - Finlandia 360
FR - Francia 339
BD - Bangladesh 295
SE - Svezia 275
RU - Federazione Russa 269
IN - India 221
JP - Giappone 193
CA - Canada 159
MX - Messico 159
AR - Argentina 143
ID - Indonesia 140
NL - Olanda 85
ZA - Sudafrica 70
IQ - Iraq 68
PK - Pakistan 65
ES - Italia 63
EC - Ecuador 57
CO - Colombia 50
AT - Austria 46
UZ - Uzbekistan 41
VE - Venezuela 41
SA - Arabia Saudita 38
BE - Belgio 35
MA - Marocco 31
PH - Filippine 31
CL - Cile 28
TN - Tunisia 28
MY - Malesia 23
EG - Egitto 22
IR - Iran 22
LT - Lituania 20
CH - Svizzera 19
KE - Kenya 19
KR - Corea 19
BO - Bolivia 17
PY - Paraguay 17
JM - Giamaica 16
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
CZ - Repubblica Ceca 15
ET - Etiopia 14
NP - Nepal 13
DZ - Algeria 12
PE - Perù 12
IL - Israele 10
JO - Giordania 10
RO - Romania 10
AL - Albania 9
GR - Grecia 9
AZ - Azerbaigian 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
HN - Honduras 8
TH - Thailandia 8
IE - Irlanda 7
KZ - Kazakistan 7
LY - Libia 7
PS - Palestinian Territory 7
PT - Portogallo 7
HU - Ungheria 6
OM - Oman 6
RS - Serbia 6
BG - Bulgaria 5
LB - Libano 5
NG - Nigeria 5
PA - Panama 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
EU - Europa 4
MD - Moldavia 4
MN - Mongolia 4
QA - Qatar 4
SN - Senegal 4
AO - Angola 3
BF - Burkina Faso 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
GT - Guatemala 3
KW - Kuwait 3
LV - Lettonia 3
MU - Mauritius 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BM - Bermuda 2
GA - Gabon 2
Totale 41.141
Salva come PNG Salva come JPEG
Città #
Fairfield 2.682
Singapore 2.545
Woodbridge 2.480
Ashburn 2.442
Houston 1.583
San Jose 1.207
Jacksonville 1.143
Seattle 1.061
Chandler 993
Hong Kong 970
Ann Arbor 893
Wilmington 880
Cambridge 859
Santa Clara 741
Beijing 718
Izmir 415
Warsaw 402
Ho Chi Minh City 360
Nanjing 335
Los Angeles 317
Hanoi 255
Princeton 251
Dallas 250
San Diego 234
New York 215
Lauterbourg 204
Boardman 194
Tokyo 183
Ferrara 155
Milan 142
Munich 142
Addison 121
São Paulo 105
Helsinki 101
Dong Ket 96
Shanghai 96
Mexico City 95
Nanchang 94
Shenyang 92
Jakarta 89
Orem 89
Hefei 82
Dearborn 76
Atlanta 74
Chicago 68
Hebei 68
Tianjin 68
London 65
Council Bluffs 61
Buffalo 59
Mountain View 59
Jinan 57
Bremen 55
Da Nang 55
Brooklyn 54
Jiaxing 53
The Dalles 49
Rome 47
Montreal 46
Haiphong 45
San Francisco 45
Changsha 44
Denver 44
Kunming 43
Rio de Janeiro 42
Turku 42
Hangzhou 41
Johannesburg 41
Chennai 40
Falls Church 40
Moscow 40
Redwood City 39
Toronto 39
Columbus 37
Frankfurt am Main 36
Norwalk 36
San Mateo 36
Tashkent 36
Manchester 35
Falkenstein 34
Guangzhou 34
Zhengzhou 33
Nuremberg 32
Phoenix 32
Stockholm 32
Brussels 31
Mumbai 31
Boston 30
Amsterdam 28
Hải Dương 28
Poplar 28
Tappahannock 28
Brasília 27
Orange 27
Belo Horizonte 26
Des Moines 26
Ningbo 26
Philadelphia 25
Verona 24
Washington 24
Totale 28.732
Salva come PNG Salva come JPEG
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 360
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 302
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 301
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 291
Loss of miR-204 expression is a key event in melanoma 283
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 276
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 275
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 271
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 268
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 264
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 258
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 258
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 256
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 256
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 255
MicroRNA expression profiling in human Barrett's carcinogenesis. 254
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 253
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 251
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 249
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 248
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 238
MicroRNA involvement in hepatocellular carcinoma 236
Identification of microRNA activity by Targets' Reverse EXpression. 236
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 233
MicroRNA e cancro 233
A microRNA DNA methylation signature for human cancer metastasis 231
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 230
Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo 228
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 226
Reprogramming of miRNA networks in cancer and leukemia 225
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 225
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 223
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 222
Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status 219
A microRNA signature of hypoxia 218
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 218
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 217
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 216
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 215
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 214
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 213
microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer 213
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 211
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 210
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 210
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 209
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 209
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 208
Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer 208
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 205
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 205
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 205
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 203
miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model 202
Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis 201
Espressione dei MicroRNA nei carcinomi mammari 201
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 199
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 198
Aberrant FHIT transcripts in Merkel cell carcinoma 197
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 197
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 196
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 195
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 195
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 194
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 194
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 193
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 192
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 191
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 190
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 190
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 189
Tumor suppressor functions of ARLTS1 in lung cancers 189
Mutated beta-catenin evades a microRNA-dependent regulatory loop 188
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 187
Knockout mice reveal a tumor suppressor function for Testin 187
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 187
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 186
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 185
Extensive modulation of a set of microRNAs in primary glioblastoma 185
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization 184
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 184
The role of microRNA genes in papillary thyroid carcinoma 183
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 182
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 182
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 182
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 180
MicroRNA-133 controls cardiac hypertrophy 178
MicroRNA deregulation in human thyroid papillary carcinomas 178
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 178
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 177
Alternative splicing, genomic structure, and fine chromosome localization of REV3L 176
MicroRNA profiles discriminate among colon cancer metastasis 173
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms 172
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 172
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 172
Modulation of mismatch repair and genomic stability by miR-155 172
MicroRNA genes are frequently located near mouse cancer susceptibility loci 171
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers 171
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 171
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 170
Totale 21.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 178.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.491
Totale 179.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021278 0 0 0 0 0 0 0 0 0 0 0 278
2021/20222.731 124 318 263 67 95 108 151 135 80 201 287 902
2022/20232.423 249 98 61 306 380 391 103 259 323 19 131 103
2023/20241.074 126 169 60 38 79 182 32 69 23 18 30 248
2024/20254.586 144 94 387 137 585 360 160 283 851 471 649 465
2025/202614.110 1.194 650 1.219 1.860 1.889 828 1.714 812 1.523 1.459 726 236
Totale 41.513